Business Description
Li Kang Biomedical Co Ltd
NAICS : 333316
ISIN : TW0006242001
Description
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.97 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | 0.67 | |||||
| Interest Coverage | 215.81 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 7.31 | |||||
| Beneish M-Score | -2.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.3 | |||||
| 3-Year EBITDA Growth Rate | 14 | |||||
| 3-Year EPS without NRI Growth Rate | 18.4 | |||||
| 3-Year FCF Growth Rate | 5.5 | |||||
| 3-Year Book Growth Rate | 7.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.02 | |||||
| 9-Day RSI | 46.1 | |||||
| 14-Day RSI | 43.87 | |||||
| 6-1 Month Momentum % | -0.63 | |||||
| 12-1 Month Momentum % | -19.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.24 | |||||
| Quick Ratio | 2.86 | |||||
| Cash Ratio | 2.74 | |||||
| Days Inventory | 73.39 | |||||
| Days Sales Outstanding | 5.21 | |||||
| Days Payable | 36.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.73 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| 3-Year Dividend Growth Rate | 6.5 | |||||
| Forward Dividend Yield % | 3.73 | |||||
| 5-Year Yield-on-Cost % | 3.14 | |||||
| Shareholder Yield % | 1.88 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.71 | |||||
| Operating Margin % | 21.19 | |||||
| Net Margin % | 17.64 | |||||
| FCF Margin % | 14.85 | |||||
| ROE % | 18.63 | |||||
| ROA % | 14.8 | |||||
| ROIC % | 24.47 | |||||
| ROC (Joel Greenblatt) % | 44.77 | |||||
| ROCE % | 22.15 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.57 | |||||
| PE Ratio without NRI | 12.57 | |||||
| Shiller PE Ratio | 18.19 | |||||
| Price-to-Owner-Earnings | 14.45 | |||||
| PEG Ratio | 2.1 | |||||
| PS Ratio | 2.3 | |||||
| PB Ratio | 2.28 | |||||
| Price-to-Tangible-Book | 2.28 | |||||
| Price-to-Free-Cash-Flow | 15.48 | |||||
| Price-to-Operating-Cash-Flow | 14.95 | |||||
| EV-to-EBIT | 10.7 | |||||
| EV-to-EBITDA | 9.87 | |||||
| EV-to-Revenue | 2.37 | |||||
| EV-to-FCF | 16.03 | |||||
| Price-to-Projected-FCF | 1 | |||||
| Price-to-Median-PS-Value | 1.08 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.47 | |||||
| Price-to-Graham-Number | 1.13 | |||||
| Price-to-Net-Current-Asset-Value | 9.06 | |||||
| Price-to-Net-Cash | 13.81 | |||||
| Earnings Yield (Greenblatt) % | 9.35 | |||||
| FCF Yield % | 5.51 | |||||
| Forward Rate of Return (Yacktman) % | 15.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Li Kang Biomedical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 629.379 | ||
| EPS (TTM) (NT$) | 4.123 | ||
| Beta | -0.5 | ||
| Volatility % | 14.02 | ||
| 14-Day RSI | 43.87 | ||
| 14-Day ATR (NT$) | 0.564313 | ||
| 20-Day SMA (NT$) | 51.98 | ||
| 12-1 Month Momentum % | -19.36 | ||
| 52-Week Range (NT$) | 50.2 - 68.523386 | ||
| Shares Outstanding (Mil) | 32.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Li Kang Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Li Kang Biomedical Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Li Kang Biomedical Co Ltd Frequently Asked Questions
What is Li Kang Biomedical Co Ltd(ROCO:6242)'s stock price today?
The current price of ROCO:6242 is NT$51.80. The 52 week high of ROCO:6242 is NT$68.52 and 52 week low is NT$50.20.
When is next earnings date of Li Kang Biomedical Co Ltd(ROCO:6242)?
The next earnings date of Li Kang Biomedical Co Ltd(ROCO:6242) is .
Does Li Kang Biomedical Co Ltd(ROCO:6242) pay dividends? If so, how much?
The Dividend Yield %  of Li Kang Biomedical Co Ltd(ROCO:6242) is 3.73% (As of Today), Highest Dividend Payout Ratio of Li Kang Biomedical Co Ltd(ROCO:6242) was 1.21. The lowest was 0.02. And the median was 0.56. The  Forward Dividend Yield % of Li Kang Biomedical Co Ltd(ROCO:6242) is 3.73%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers